CompletedNot Applicable

LeMaitre LifeSpan® ePTFE Vascular Graft Retrospective Registry

Germany153 participantsStarted 2020-11-27

Plain-language summary

This is a post-market, single-arm, retrospective registry. The investigator or its representative will identify eligible patients through a medical record search.

Who can participate

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Subject has undergone surgical treatment with the LifeSpan. * Surgical treatment was for bypass or reconstruction of diseased or occluded blood vessels (PVP group) or arteriovenous shunting for blood access (AV group). * For PVP group: Subject's surgical treatment was at minimum 3 years ago, and maximum 10 years ago, at time of enrollment. * For AV group: Subject's surgical treatment was at minimum 2 years ago, and maximum 10 years ago, at time of enrollment. Exclusion Criteria: * None

What they're measuring

Percentage of vessels patent without requiring intervention to remain open

Timeframe: 3 years

Percentage of vessels patent without requiring intervention to remain open

Timeframe: 2 years

Trial details

NCT IDNCT04620889

SponsorLeMaitre Vascular

Sponsor typeINDUSTRY

Study typeOBSERVATIONAL

Primary completion2023-11-24

View on ClinicalTrials.gov More Diseased or Occluded Blood Vessels trials